We are monitoring the impact of COVID-19 on Europe Smart Inhalers Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5828
Share on
Share on

Europe Smart Inhalers Market Research Report - Segmented By Product Type, Disorder, End-user and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2020 to 2025)

Pulished: February, 2020
ID: 5828
Pages: 145

Europe Smart Inhalers Market Size (2020 to 2025)

The size of the Smart Inhalers Market in Europe was worth USD 5.18 million in 2019 and estimated to be growing at a CAGR of 64.77% to reach USD 62.87 million by 2024. 

The rise in the incidence of respiratory diseases is majorly driving the growth of the market in Europe. Growing focus on the development of new devices in the medical sector is straight, elevating the demand for the smart inhalers market. These devices are beneficial for the physicians to track their patient’s inhale usage, which is additionally accelerating the growth rate of the market. The growing prevalence of effective treatment procedures and to improve the quality of drugs is promoting the growth rate of the market in Europe. Easy availability of the devices in pharmaceutical stores and also in online stores is expanding the size of the market. Smart inhalers are very accurate and promote the best treatment for patients who have asthma and chronic obstructive pulmonary diseases. The factor mentioned before is bolstering the demand of the market to the extent in Europe.

Additionally, the rise in air pollution, which causes disorders like asthma and COPD, the inclination of patients towards digitalized medical devices, increasing aging population are further accelerating the market growth. Rising awareness about medication, increasing investments in R&D of medical devices, growing respiratory diseases, new product innovations in the pharmaceutical industry, and the technological advancements in the pharma-medical devices industry are driving the Europe Smart Inhalers Market. However, limitations in data privacy, high costs, and lack of availability in many regions are hindering the market growth.

This research report segmented and sub-segmented into the following categories:

  • By Product Type: Nebulizers, Inhalers
  • By Disorder: Chronic Obstructive Pulmonary Disease, Asthma and Other
  • End-user: Patients, R&D, and Others
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

In Europe, the Germany Smart Inhalers market is positioned top is holding the highest shares of the European market by owing to the launch of innovative products with the help of the latest technologies. The growing tendency to improve healthcare services is leveraging the demand of the market. Also, government investments in developing new devices in the medical sector are elevating the growth rate of the European smart inhalers market.

Smart Inhalers market in France and the UK are following Germany in holding prominent shares of the market. Rise in the support from the IT sector in introducing smart inhalers with the sensors attached where a physician can have complete data of the usage of the inhaler by the patient, and this will help them to do appropriate treatment is magnifying the demand of the market.

Italy, Spain, and the Rest of Europe smart inhaler markets are anticipated to have inclined growth rates in coming years with the increasing popularity of these devices and its benefits. Rise in the scale of pharmaceutical companies in these countries is to boost up the demand for the smart inhalers market.

Key players operating in the Europe Smart Inhalers Market profiled in this report are Vectura Group plc, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca plc, Adherium Limited, Cohero Health, LLC, Propeller Health, GlaxoSmithKline plc and OPKO Health, Inc.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product                                                        

                                5.1.1 Introduction                                           

                                5.1.2 Nebulizers                                               

                                5.1.3 Inhalers                                    

                                                5.1.3.1 Metered Dose Inhalers (MDIs)                   

                                                5.1.3.2 Dry Powder Inhalers (DPIs)                          

                                5.1.4 Y-o-Y Growth Analysis, By Product                                               

                                5.1.5 Market Attractiveness Analysis, By Product                                             

                                5.1.6 Market Share Analysis, By Product                                               

                5.2 Disorder                                                       

                                5.2.1 Introduction                                           

                                5.2.2 Chronic Obstructive Pulmonary Disease (COPD)                                     

                                5.2.3 Asthma                                     

                                5.2.4 Others                                      

                                5.2.5 Y-o-Y Growth Analysis, By Disorder                                              

                                5.2.6 Market Attractiveness Analysis, By Disorder                                            

                                5.2.7 Market Share Analysis, By Disorder                                              

                5.3 End-user                                                      

                                5.3.1 Introduction                                           

                                5.3.2 Patients                                    

                                5.3.3 R&D                                           

                                5.3.4 Others                                      

                                5.3.5 Y-o-Y Growth Analysis, By End-user                                             

                                5.3.6 Market Attractiveness Analysis, By End-user                                           

                                5.3.7 Market Share Analysis, By End-user                                             

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product                           

                                                6.1.3.3 By Disorder                         

                                                6.1.3.4 By End-user                        

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product                           

                                                6.1.4.3 By Disorder                         

                                                6.1.4.4 By End-user                        

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product                           

                                                6.1.5.3 By Disorder                         

                                                6.1.5.4 By End-user                        

                6.2 U.K                                                 

                6.3 Spain                                                             

                6.4 Germany                                                     

                6.5 Italy                                                               

                6.6 France                                                          

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Vectura Group plc                                                   

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Teva Pharmaceutical Industries Ltd.,                                                               

                8.3 GlaxoSmithKline plc                                                

                8.4 Boehringer Ingelheim GmbH                                                              

                8.5 AstraZeneca plc,                                                       

                8.6 Adherium Limited                                                    

                8.7 Cohero Health, LLC,                                                                

                8.8 Propeller Health                                                       

                8.9 GlaxoSmithKline plc                                                

                8.10 OPKO Health, Inc.                                                  

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Europe and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by product type, along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Europe Smart Inhalers Market, By Product Type, From 2020 to 2025 (USD Million)
  2. Europe Nebulizers Market, By Region, From 2020 to 2025 (USD Million)
  3. Europe Inhalers  Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  5. Europe Chronic Obstructive Pulmonary Disease Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe Asthma Market, By Region, From 2020 to 2025 (USD Million)
  7. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  8. Europe Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)
  9. Europe Patients Market, By Region, From 2020 to 2025 (USD Million)
  10. Europe R&D Market, By Region, From 2020 to 2025 (USD Million)
  11. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  12. U.K. Smart Inhalers Market, By Product Type, From 2020 to 2025 (USD Million)
  13. U.K. Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  14. U.K. Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)
  15. Germany Smart Inhalers Market, By Product Type, From 2020 to 2025 (USD Million)
  16. Germany Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  17. Germany Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)
  18. France Smart Inhalers Market, By Product Type, From 2020 to 2025 (USD Million)
  19. France Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  20. France Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)
  21. Italy Smart Inhalers Market, By Product Type, From 2020 to 2025 (USD Million)
  22. Italy Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  23. Italy Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)
  24. Spain Smart Inhalers Market, By Product Type, From 2020 to 2025 (USD Million)
  25. Spain Smart Inhalers Market, By Disorder, From 2020 to 2025 (USD Million)
  26. Spain Smart Inhalers Market, By End-user, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample